Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Ratain

Showing results (11-20 of 225) with videos related to

Pageof 23
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 28, 2002
Update on pharmacogenetics in cancer chemotherapyF Innocenti, M J Ratain
Cancer Chemotherapy and Pharmacology|January 1, 1994
Pharmacodynamics and long-term toxicity of etoposideK Kobayashi, M J Ratain
Investigational New Drugs|June 8, 2001
Body surface area as a determinant of pharmacokinetics and drug dosingM Sawyer, M J Ratain
Cancer Chemotherapy and Pharmacology|January 1, 1994
Phase I study of escalating does of carboplatinR Mick, M J Ratain
Seminars in Oncology|February 1, 1993
Individualizing dosing of cancer chemotherapyK Kobayashi, M J Ratain
Cancer Investigation|October 13, 1999
5-fluorouracil pharmacokinetics: causes for variability and strategies for modulation in cancer chemotherapyL Iyer, M J Ratain
Cancer Investigation|April 9, 2001
Screening for sources of interindividual pharmacokinetic variability in anticancer drug therapy: utility of population analysisH Kastrissios, M J Ratain
Seminars in Oncology|December 1, 1992
New perspectives on the toxicity of etoposideK Kobayashi, M J Ratain
Journal of the National Cancer Institute|November 6, 1991
Modeling interpatient pharmacodynamic variability of etoposideR Mick, M J Ratain
Current Opinion in Oncology|November 1, 1996
Promising new agents in oncologic treatmentS Mani, M J Ratain
Pageof 23

Showing results (11-20 of 225) with videos related to

Sort By:
Pageof 23
European Journal of Cancer (Oxford, England : 1990)|March 28, 2002
Update on pharmacogenetics in cancer chemotherapyF Innocenti, M J Ratain
Cancer Chemotherapy and Pharmacology|January 1, 1994
Pharmacodynamics and long-term toxicity of etoposideK Kobayashi, M J Ratain
Investigational New Drugs|June 8, 2001
Body surface area as a determinant of pharmacokinetics and drug dosingM Sawyer, M J Ratain
Cancer Chemotherapy and Pharmacology|January 1, 1994
Phase I study of escalating does of carboplatinR Mick, M J Ratain
Seminars in Oncology|February 1, 1993
Individualizing dosing of cancer chemotherapyK Kobayashi, M J Ratain
Cancer Investigation|October 13, 1999
5-fluorouracil pharmacokinetics: causes for variability and strategies for modulation in cancer chemotherapyL Iyer, M J Ratain
Cancer Investigation|April 9, 2001
Screening for sources of interindividual pharmacokinetic variability in anticancer drug therapy: utility of population analysisH Kastrissios, M J Ratain
Seminars in Oncology|December 1, 1992
New perspectives on the toxicity of etoposideK Kobayashi, M J Ratain
Journal of the National Cancer Institute|November 6, 1991
Modeling interpatient pharmacodynamic variability of etoposideR Mick, M J Ratain
Current Opinion in Oncology|November 1, 1996
Promising new agents in oncologic treatmentS Mani, M J Ratain
Pageof 23